BSE filing, NSE: KAPILCO. Summary written from the filing by ALFA Finder's alert engine.
Skybiotech Healthcare Ltd: key numbers
- Share price
- ₹116.00
- Market cap
- ₹22.21 Cr
- Revenue (annual)
- ₹7.10 Cr
- Net profit (annual)
- ₹-1.12 Cr
- P/E (TTM)
- -13.3×Sector 49.8×
- Promoter holding
- 63.48%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Skybiotech Healthcare Ltd
All →Skybiotech Healthcare Other Announcement
This is a routine quarterly shareholding pattern filing for Skybiotech Healthcare Ltd in compliance with SEBI Regulation 31(1)(b).
Skybiotech Healthcare Annual General Meeting
Skybiotech Healthcare Limited held its 43rd Annual General Meeting on September 30, 2026. Shareholders approved audited financial statements, director re-appointment, and the appointment of statutory auditors.
Skybiotech Healthcare Annual General Meeting
Skybiotech Healthcare Ltd has issued the notice for its 43rd Annual General Meeting. The meeting is scheduled to be held on September 30, 2026.
Skybiotech Healthcare Annual Report
Skybiotech Healthcare Ltd has filed its Annual Report for the financial year 2025-26, pursuant to Regulation 34 of the SEBI LODR Regulations.
Skybiotech Healthcare Q1 FY27 Results: Net Loss of ₹0.6 Cr
Skybiotech Healthcare Ltd reported revenue from operations of ₹0.5 Cr (-79.2% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.6 Cr
Skybiotech Healthcare Board Meeting Date
Skybiotech Healthcare Limited has scheduled a board meeting for August 14, 2026. The board will consider and approve un-audited financial results for the quarter ended June 30, 2026.
Other debt & borrowing announcements
All →QGO Finance Debt & Borrowing: ₹1 Cr
QGO Finance Ltd has redeemed 100 unlisted non-convertible debentures, with a total value of Rs. 1 Crore, including the principal and applicable interest.
- Value
- ₹1.00 Cr
Capri Global Capital Debt & Borrowing: ₹1.42 Cr
Capri Global paid interest on four listed NCD series ahead of their due dates, totalling Rs.1.42 Crore. The Reg 57 certificate reports no payment changes or delays.
- Value
- ₹1.42 Cr
Ugro Capital Debt & Borrowing: ₹2.99 Cr
Ugro Capital paid Rs 2.99 Crore in interest on two NCD series on 29 October 2026. Payments were made a day before the 30 October due date.
- Value
- ₹2.99 Cr
Time Technoplast Debt & Borrowing: ₹50 Cr
Time Technoplast redeemed its Rs.50 Crore commercial paper in full on maturity on 29 October 2026. The redemption completes servicing of this short-term debt instrument.
- Value
- ₹50.00 Cr
Samvardhana Motherson International Debt & Borrowing: ₹834.8 Cr
Samvardhana Motherson issued a corporate guarantee for a EUR 75 million BNP Paribas term facility of subsidiary MGI B.V. Liability capped at ₹834.75 Crore.
- Value
- ₹834.8 Cr
- Execution
- Guarantee valid up to February 28, 2032
Electrotherm (India) Debt & Borrowing: ₹59.81 Cr
Electrotherm disclosed a Rs 59.81 Crore default on bank loans as at 30 September 2026. The loans were assigned to an ARC under a settlement.
- Value
- ₹59.81 Cr